Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

ClinicalTrials.gov ID: NCT01345019

Public ClinicalTrials.gov record NCT01345019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Disease in Subjects With Newly Diagnosed Multiple Myeloma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if denosumab is non-inferior to zoledronic acid in the treatment of bone disease from multiple myeloma.

Study identification

NCT ID
NCT01345019
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
1,718 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 17, 2012 (Actual)
Primary completion
Jul 19, 2016 (Actual)
Completion
Mar 29, 2019 (Actual)
Last update posted
Nov 8, 2022

2012 – 2019

United States locations

U.S. sites
79
U.S. states
36
U.S. cities
70
Facility City State ZIP Site status
Research Site Tucson Arizona 85704 —
Research Site Fayetteville Arkansas 72703 —
Research Site Anaheim California 92801 —
Research Site Campbell California 95008 —
Research Site Encinitas California 92024 —
Research Site Fresno California 93720 —
Research Site Pleasant Hill California 94523 —
Research Site Santa Barbara California 93105 —
Research Site Santa Maria California 93454 —
Research Site Stamford Connecticut 06902 —
Research Site Washington D.C. District of Columbia 20007 —
Research Site Washington D.C. District of Columbia 20010 —
Research Site Boynton Beach Florida 33426 —
Research Site Boynton Beach Florida 33435 —
Research Site Jacksonville Florida 32256 —
Research Site Columbus Georgia 31904 —
Research Site Savannah Georgia 31405 —
Research Site Chicago Illinois 60612 —
Research Site Joliet Illinois 60435 —
Research Site Maywood Illinois 60153 —
Research Site Niles Illinois 60714 —
Research Site Skokie Illinois 60076 —
Research Site Skokie Illinois 60077 —
Research Site Anderson Indiana 46016 —
Research Site Fort Wayne Indiana 46845 —
Research Site Indianapolis Indiana 46202 —
Research Site Ames Iowa 50010 —
Research Site Iowa City Iowa 52242 —
Research Site Paducah Kentucky 42003 —
Research Site New Orleans Louisiana 70121 —
Research Site Scarborough Maine 04074 —
Research Site Baltimore Maryland 21204 —
Research Site Baltimore Maryland 21229 —
Research Site Baltimore Maryland 21237 —
Research Site Bethesda Maryland 20817 —
Research Site Westminster Maryland 21157 —
Research Site Boston Massachusetts 02114 —
Research Site Boston Massachusetts 02215 —
Research Site Danvers Massachusetts 01923 —
Research Site Fairhaven Massachusetts 02719 —
Research Site Detroit Michigan 48201 —
Research Site Lansing Michigan 48910 —
Research Site Jackson Mississippi 39216 —
Research Site Springfield Missouri 65806 —
Research Site Billings Montana 59101 —
Research Site Lincoln Nebraska 68506 —
Research Site Omaha Nebraska 68198 —
Research Site North Las Vegas Nevada 89086 —
Research Site Hackensack New Jersey 07601 —
Research Site Lake Success New York 11042 —
Research Site New York New York 10021 —
Research Site Rochester New York 14621 —
Research Site Fayetteville North Carolina 28304 —
Research Site Goldsboro North Carolina 27534 —
Research Site High Point North Carolina 27262 —
Research Site Bismarck North Dakota 58501 —
Research Site Oklahoma City Oklahoma 73120-8345 —
Research Site Hershey Pennsylvania 17033 —
Research Site Philadelphia Pennsylvania 19106 —
Research Site Philadelphia Pennsylvania 19140 —
Research Site Philadelphia Pennsylvania 19141 —
Research Site West Reading Pennsylvania 19611 —
Research Site Charleston South Carolina 29406 —
Research Site Charleston South Carolina 29414 —
Research Site Greenville South Carolina 29615 —
Research Site Aberdeen South Dakota 57401 —
Research Site Rapid City South Dakota 57701 —
Research Site Sioux Falls South Dakota 57105 —
Research Site Watertown South Dakota 57201 —
Research Site Memphis Tennessee 38120 —
Research Site Houston Texas 77030 —
Research Site Lubbock Texas 79415 —
Research Site Salt Lake City Utah 84106 —
Research Site Christiansburg Virginia 24073 —
Research Site Spokane Washington 99208 —
Research Site Tacoma Washington 98405 —
Research Site Morgantown West Virginia 26506 —
Research Site Minocqua Wisconsin 54548 —
Research Site Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 230 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01345019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 8, 2022 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01345019 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →